(Q47951468)

English

Psychomotor slowing, negative symptoms and dopamine receptor availability--an IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients.

scientific article published in May 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9633833

Psychomotor slowing, negative symptoms and dopamine receptor availability--an IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients. (English)

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9633833

0 references

0 references

0 references

author name string

A Heinz

1

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9633833

M B Knable

2

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9633833

R Coppola

3

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9633833

J G Gorey

4

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9633833

D W Jones

5

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9633833

K S Lee

6

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9633833

D R Weinberger

7

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9633833

language of work or name

0 references

publication date

1 May 1998

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9633833

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Schizophrenia Research

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9633833

31

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9633833

19-26

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9633833

1

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9633833

Negative symptoms in schizophrenia. Definition and reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900003-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Serotonin potentiates dopamine inhibition of ventral tegmental area neurons in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900003-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900003-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of sensorimotor and cognitive performance of acute schizophrenic inpatients treated with remoxipride or haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900003-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Laterality in schizophrenia. A reaction time study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900003-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Anhedonia in schizophrenic, depressed, or alcohol-dependent patients--neurobiological correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900003-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cognitive components of reaction time in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900003-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Altered dopaminergic function and negative symptoms in drug-free patients with schizophrenia. [123I]-iodobenzamide SPECT study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900003-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900003-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The assessment and analysis of handedness: The Edinburgh inventory

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900003-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The neural basis of drug craving: an incentive-sensitization theory of addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900003-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Negative symptoms and reaction time in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900003-6

7 January 2021

based on heuristic

inferred from DOI database lookup

D2 dopamine receptor occupancy: a crossover comparison of risperidone with clozapine therapy in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900003-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications of normal brain development for the pathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900003-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900003-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Motor proficiency and attentional-task performance by psychotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900003-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The neurobiology of craving: implications for the understanding and treatment of addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900003-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0920-9964(98)00003-6

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9633833

release_fixchyznozbe7fgzamesk6coqq

1 reference

https://api.fatcat.wiki/v0/release/fixchyznozbe7fgzamesk6coqq

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9633833

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47951468&oldid=1844653806"